Search results
Results from the WOW.Com Content Network
Olmesartan, sold under the brand name Benicar among others, is a medication used to treat high blood pressure (hypertension). [1] [2] It is taken orally (swallowed by mouth). [2] Versions are available as the combination olmesartan/hydrochlorothiazide and olmesartan/amlodipine. [2] It is available as a prodrug, olmesartan medoxomil.
Azilsartan, sold under the brand name Edarbi among others, is used for the treatment of hypertension. [2] [3] [4] It is used as the prodrug azilsartan medoxomil, is an angiotensin II receptor antagonist, [5] and was developed by Takeda. The most common adverse reaction in adults is diarrhea. [2] It is available as a generic medication. [6]
Olmesartan/hydrochlorothiazide, sold under the brand name Benicar HCT among others, is a fixed-dose combination medication used to treat high blood pressure. [1] [2] It is a combination of olmesartan medoxomil, an angiotensin II receptor blocker and hydrochlorothiazide, a diuretic. [2]
It contains olmesartan medoxomil, an angiotensin II receptor blocker, amlodipine, as the besilate, a calcium channel blocker, and hydrochlorothiazide, a thiazide diuretic. [3] It is taken by mouth . [ 3 ]
Amlodipine/olmesartan, sold under the brand name Azor, among others is a fixed-dose combination medication used to treat high blood pressure. [5] It contains amlodipine, as the besilate, a dihydropyridine calcium channel blocker, and olmesartan medoxomil, an angiotensin II receptor blocker.
Losartan, the first ARB. Angiotensin II receptor blockers (ARBs), formally angiotensin II receptor type 1 (AT 1) antagonists, [1] also known as angiotensin receptor blockers, [2] [3] angiotensin II receptor antagonists, or AT 1 receptor antagonists, are a group of pharmaceuticals that bind to and inhibit the angiotensin II receptor type 1 (AT 1) and thereby block the arteriolar contraction and ...
The prodrug form faropenem medoxomil [4] (also known as faropenem daloxate) has been licensed from Daiichi Asubio Pharma by Replidyne, ...
This page was last edited on 19 February 2006, at 00:15 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.